Dilawari, A. http://orcid.org/0000-0001-5706-9138
Rentscher, K. E.
Zhai, W.
Zhou, X.
Ahles, T. A.
Ahn, J.
Bethea, T. N.
Carroll, J. E.
Cohen, H. J.
Graham, D. A.
Jim, H. S. L.
McDonald, B.
Nakamura, Z. M.
Patel, S. K.
Root, J. C.
Small, B. J.
Saykin, A. J.
Tometich, D.
Van Dyk, K.
Mandelblatt, J. S.
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy
https://doi.org/10.1007/s10549-022-06597-1
Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors
https://doi.org/10.1007/s10549-021-06362-w
Funding for this research was provided by:
National Cancer Institute (R01CA129769, R01CA172119, K01CA212056, R01CA237535, K08CA241337, R35CA197289, R01AG068193, P30CA008748)
National Institutes of Health (P30CA51008, K12HD001441)
National Institute on Aging (K01AG065485, P30AG10133, P30AG10133, P30AG028716, R01AG19771, R01LM01136, R01AG19771, R01LM01136)
Norman Cousins Center for Psychoneuroimmunology
American Cancer Society (128660-RSG-15-187-01-PCSM, RSG-17-023-01-CPPB)
Article History
Received: 7 April 2021
Accepted: 8 August 2021
First Online: 13 September 2021
Declarations
:
: AAD attended the Cardinal Health 2020 Advisor Board Oncology Committee. HSJ: Consulting or Advisory Role: Janssen Pharmaceuticals and RedHill Biopharma. DG: Stock and Other Ownership Interests: Cota. AJS: Consulting or Advisory Role: Bayer AG Research Funding: Eli Lilly (Inst).
: The study protocol was approved by the Institutional Review Boards at all sites (ClinicalTrials.gov Identifier: NCT03451383).
: All participants provided informed consent.
: All authors have approved the final manuscript and provided consent for publication. The results have not been published or presented elsewhere.
Free to read: This content has been made available to all.